Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer

European Journal of Pharmaceutics and Biopharmaceutics(2020)10.1016/j.ejpb.2020.11.007Source: DataRank Database

Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer is a research paper published in European Journal of Pharmaceutics and Biopharmaceutics (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (57)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ebony Nottingham,Arvind Bagde,Nilkumar Patel,Arun K. Rishi ORCID,Satyanarayan Dev ORCID

Live enrichment

PubMed:33220423 PMC:PMC7857068

BLRD VA

Grant: IK6 BX004015

BLRD VA

Grant: I01 BX001164

NIMHD NIH HHS

Grant: U54 MD007582

NIMHD NIH HHS

Grant: G12 MD007582

National Institutes of Health

Grant: 5U54MD007582-37

FAMU Center for Health Disparities Research

National Science Foundation

National Institutes of Health

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7857068

publisherhttps://api.elsevier.com/content/article/PII:S0939641120303362?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0939641120303362?httpAccept=text/plain

https://doi.org/10.1016/j.ejpb.2020.11.007

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857068

Fields of Study

02 engineering and technology03 medical and health sciences0302 clinical medicine0210 nano-technology

MeSH Terms

Cell Line, TumorAnimalsHumansRatsCarcinoma, Non-Small-Cell LungLung NeoplasmsAcrylamidesAniline CompoundsPyrimidinesThiadiazolesIndolesSpiro CompoundsLipidsCell Cycle ProteinsAntineoplastic Combined Chemotherapy ProtocolsDrug CarriersProtein Kinase InhibitorsAdministration, OralModels, AnimalBiological AvailabilityDrug Resistance, NeoplasmMaleApoptosis Regulatory ProteinsNanoparticlesMolecular Docking SimulationDrug LiberationErbB Receptors

Keywords

Drug resistanceCancerSustained-releaseOral BioavailabilityQuality By DesignNano Lipid FormulationMaleAcrylamidesDrug CarriersAniline CompoundsLung NeoplasmsAdministration, OralBiological AvailabilityCell Cycle ProteinsLipidsErbB ReceptorsMolecular Docking SimulationDrug LiberationDrug Resistance, NeoplasmCarcinoma, Non-Small-Cell LungCell Line, TumorAntineoplastic Combined Chemotherapy ProtocolsModels, AnimalAnimalsHumansApoptosis Regulatory Proteins

Sustainable Development Goals

SDG 3: 3. Good health

Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer

FAIR Checklist

Authors (7)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)